Stock Earnings

Question 1

How did MLTX's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for MoonLake Immunotherapeutics is $-0.87, beating expectations of $-0.73.

Question 2

How did MoonLake Immunotherapeutics MLTX's revenue perform in the last quarter?

Accepted Answer

MoonLake Immunotherapeutics revenue for the last quarter is $-0.87

Question 3

What is the revenue estimate for MoonLake Immunotherapeutics?

Accepted Answer

According to 16 of Wall street analyst, the revenue estimate of MoonLake Immunotherapeutics range from $0.0 to $0.0

Question 4

What's the earning quality score for MoonLake Immunotherapeutics?

Accepted Answer

MoonLake Immunotherapeutics has a earning quality score of B+/53.819584. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does MoonLake Immunotherapeutics report earnings?

Accepted Answer

MoonLake Immunotherapeutics next earnings report is expected in 2025-11-03

Question 6

What are MoonLake Immunotherapeutics's expected earnings?

Accepted Answer

MoonLake Immunotherapeutics expected earnings is $0.0, according to wall-street analysts.

Question 7

Did MoonLake Immunotherapeutics beat earnings expectations?

Accepted Answer

MoonLake Immunotherapeutics recent earnings of $0.0 does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '25	$-0.73	$-0.87	+19.17%	BEAT
Q1 '25	$-0.76	$-0.63	-17.1%	MISSED
Q4 '24	$-0.6	$-0.72	+20.0%	BEAT
Q3 '24	$-0.44	$-0.56	+27.27%	BEAT
Q2 '24	$-0.28	$-0.39	+39.28%	BEAT

MoonLake Immunotherapeutics (MLTX) Price

MLTX Stock Price Chart

Latest Earnings Results: Q2 '25

Historical Earnings

Earnings FAQ